Laurion Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Laurion Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-122,153	Closed	-$710K	–	1300
2019 Q1	$710K	Buy	+122,153	New	+$1.26M	0.01%	569
2018 Q2	–	Sell	-231,490	Closed	-$4.67M	–	1708
2018 Q1	$4.67M	Buy	+231,490	New	+$5.4M	0.04%	385
2017 Q1	–	Sell	-12,500	Closed	-$158K	–	1678
2016 Q4	$158K	Buy	+12,500	New	+$233K	﹤0.01%	1034
2016 Q1	–	Sell	-8,800	Closed	-$301K	–	1219
2015 Q4	$301K	Buy	+8,800	New	+$275K	﹤0.01%	705
2015 Q2	–	Sell	-116,901	Closed	-$4.04M	–	727
2015 Q1	$4.04M	Buy	116,901 +68,901	+144%	+$1.87M	0.08%	177
2014 Q4	$1.31M	Buy	+48,000	New	+$1.16M	0.03%	153

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurion Capital Management's DPLO Position: Q2 2019 in Review

Laurion Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 122,153 shares — an estimated $710K sold.

Laurion Capital Management first reported a position in DPLO in Q4 2014 and held it in 6 quarters. The position peaked at $4.67M in Q1 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

Laurion Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
Laurion Capital Management sold 122,153 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $710K.
Laurion Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 6 quarters.
Laurion Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $4.67M in Q1 2018.
131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.